PT - JOURNAL ARTICLE AU - Bo Zhao AU - Zaizhi Yu AU - Tomonori Fujita AU - Yoshiaki Nihei AU - Hiroaki Tanaka AU - Masaru Ihara TI - Tracking community infection dynamics of COVID-19 by monitoring SARS-CoV-2 RNA in wastewater, counting positive reactions by qPCR AID - 10.1101/2021.12.23.21268343 DP - 2021 Jan 01 TA - medRxiv PG - 2021.12.23.21268343 4099 - http://medrxiv.org/content/early/2021/12/24/2021.12.23.21268343.short 4100 - http://medrxiv.org/content/early/2021/12/24/2021.12.23.21268343.full AB - Wastewater-based epidemiology has proved useful for monitoring the COVID-19 infection dynamics in communities. However, in some countries, low concentrations of SARS-CoV-2 RNA in wastewater make this difficult. Getting meaningful information from wastewater-based epidemiology in regions of low prevalence remains a key challenge. Here we used real-time reverse-transcription PCR (RT-qPCR) to monitor SARS-CoV-2 RNA in wastewater from October 2020 to February 2021 during the third wave of the COVID-19 outbreak in Japan. Viral RNA was below the limit of quantification in all samples. However, by counting the positive reactions in repeated qPCR of each sample, we found that the ratio of positive reactions to all tests in wastewater was significantly correlated with the number of clinically confirmed cases by the date of symptom onset during periods of both increasing and decreasing infection. Time-step analysis indicated that COVID-19 patients excreted large amounts of virus in their feces 2 days either side of symptom onset, which wastewater surveillance could detect. The positive count method is thus useful for tracing COVID-19 dynamics in regions of low prevalence.HighlightsPositive ratio by repeated qPCR of low target-molecule numbers correlated with number expected from Poisson distribution.Positive ratio by repeated RT-qPCR of SARS-CoV-2 RNA in wastewater tracked the infection dynamics of COVID-19 in a region of low prevalence.Positive ratios correlated with number of new cases by date of symptom onset.COVID-19 patients might excrete more virus in their feces in the period from 2 days before to 2 days after symptom onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the GAP Fund Program of Kyoto University; the Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX), established by Human Resource Development Program for Science and Technology, MEXT; and JST-Mirai Program Grant Number JPMJMI18DA, from the Japan Science and Technology Agency; and JST Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) Grant Number JPMJTM20Y5, from the Japan Science and Technology Agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript